HQL

abrdn Life Sciences Investors

45 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$875K
2 -$688K
3 -$532K
4
Morgan Stanley
Morgan Stanley
New York
-$289K
5
UBS Group
UBS Group
Switzerland
-$285K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.2M
2
$9.82M
3
$3.69M
4
$1.66M
5
$1.56M
6
$1.11M
7
$1.09M
8
$1.09M
9
$954K
10
$907K
11
$907K
12
$872K
13
$841K
14
$624K
15
$480K
16
$466K
17
$452K
18
$405K
19
$404K
20
$353K
21
$335K
22
$290K
23
$290K
24
$262K
25
$251K